Price defence has always been a consideration for companies but the industry has agreed to reforms that have institutionalised a vast array of powerful new levers that could trigger a profound and enduring shift in its strategic focus.
Do the industry's agreements make the pivot to 'price defence' advocacy permanent?
September 26, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
If this makes you uncomfortable, it should, because it is the only correct response
September 16, 2025 - - Latest News -
Lilly Australia announces leadership transition as Tori Brown moves to global role
September 16, 2025 - - Latest News -
Decision-making at its nadir, exposing the cruelty of incoherence
September 16, 2025 - - Latest News -
Use of antipsychotic twice as high in aged care residents with dementia
September 15, 2025 - - Latest News -
Australian discovery advances to global Phase 3 breast cancer trial with Pfizer
September 15, 2025 - - Latest News -
Alterity Therapeutics delivers promising Phase 2 data in Multiple System Atrophy
September 15, 2025 - - Australian Biotech -
Actinogen secures FDA agreement to advance Xanamem for Alzheimer’s disease
September 15, 2025 - - Australian Biotech